PRISM BioLab Co., Ltd.

PRISM BioLab BLOG Update! (2024/10/16) Advance in Synthetic Data: Current State and Challenges Data is essential for decision making and its importance is expanding after the emergence of artificial intelligence (AI)-based technologies and methods. Even before the advent of AI, statistical analysis of real data has been widely performed to support the humans’ predictions. In the field of healthcare, however, ...... Read more https://lnkd.in/gWaam8wz

CITELINE Japan Award 2024 Biotech company of the year ファイナリストに選出 Followed by English translation. 医薬品産業における製薬企業とバイオテク企業の卓越性と革新性を表彰する CITELINE Japan Award 2024のBiotech Company of the Year ファイナリストに選出されました。 詳細はこちら https://lnkd.in/eJVpy6g9 === Selected as a Finalist for the CITELINE Japan Award 2024 Biotech Company of the Year We are honored to announce that we’ve been chosen as a finalist for the prestigious Biotech Company of the Year at the CITELINE Japan Award 2024, which celebrates exceptional achievements and groundbreaking innovation in the pharmaceutical and biotech industries.

PRISM BioLab BLOG Update! (2024/10/02) A Rewritten Textbook in Era of Digitalization, Personalization, Collaboration and Innovation Innovation in technology have brought about paradigm shifts in pharmaceutical science. The landscape of pharmaceutical industry has changed its appearance over the decades, driven by the necessity to adapt itself to consumer expectation, regulatory forces and...... Read more https://lnkd.in/geQaqER8

Join me at BIO-Europe in Stockholm, Sweden. I look forward to partnering and meeting friends and colleagues. Register here: https://lnkd.in/dc9ZySH2 Informa Connect

【メディア掲載情報】Followed by English translation. 日本経済新聞に当社の記事が掲載されました。 「創薬のプリズムバイオラボに熱視線　メガファーマも評価」 https://lnkd.in/gJct49wQ Notice of Article Published in the Nikkei "Prism BioLab in the Spotlight for Drug Discovery, Recognized by Major Pharma" 

PRISM BioLab BLOG Update! (2024/09/18) TIDES on the Stage: Looking Back on 2023 and Future Perspective TIDES (peptides and nucleotides) is seeing the light of the day. TIDES gained an intense attention in drug discovery and the number of the approved TIDES by FDA rose up to nine in 2023.1) The molecular entity covers 16% of ...... Read more https://lnkd.in/gA5sixYx

【PRESS RELEASE】 Followed by English translation. 当社とエーザイの共同創出品E7386についてESMO（欧州臨床腫瘍学会）年次総会においてエーザイが発表 PRISM BioLab は、2024 年 9月 13 日から9 月 17 日までスペイン・バルセロナにおいて開催される「欧州臨床腫瘍学会（European Society for Medical Oncology：ESMO）年次総会（ESMO Congress 2024）」において、当社とエーザイ株式会社により共同創出されたE7386とレンバチニブメシル酸塩（以下、[レンバチニブ」)との併用試験の結果がエーザイにより発表される予定であり、本日アブストラクト（研究概要）が開示されましたので、お知らせいたします。 詳細はこちら https://lnkd.in/gBxibrMf === Eisai to Present E7386, co-created by PRISM BioLab and Eisai, at the ESMO (European Society for Medical Oncology) Annual Meeting PRISM BioLab today announced that the interim analysis of a combination study of E7386, created through collaboration research with Eisai Co., Ltd., and Lenvatinib mesylate ( “lenvatinib”) will be presented by Eisai at the European Society for Medical Oncology (ESMO) Congress 2024, held in Barcelona, Spain from September 13 to 17, 2024. The abstract of the study has been released today. More details https://lnkd.in/geUsRnJ2

PRISM BioLab BLOG Update! (2024/09/04) Characterization of Pseudo-Natural Products Synthesized by Fragment Combination Natural products often have significant biological activity and they have been taken as the pool of drug seeds for long. In order to lead natural products druggable, they were sometimes elaborated and...... Read more https://lnkd.in/dWTMSVvY

PRISM BioLab BLOG Update! (2024/08/21) Allostery for Target Modulation: Site Prediction and Drug Design Protein function is modulated not only by competitive inhibition but also by allosteric control. The natural ligand binding site has long been targeted because the mechanism of action is clear and the assay development is relatively easy for the directly targeting drugs. Allosteric modulator of a target protein is...... Read more https://lnkd.in/gQ7sNpPW

PRISM BioLab BLOG Update! (2024/08/7) De novo Design and Efficient Synthesis of Orally Bioavailable Small Cyclic Peptides Cyclic peptides gather interests of many pharmaceutical companies due to the known high potency against various protein targets. The conformationally restricted structure with ...... Read more https://lnkd.in/g8ZqyxGM